Dr. Loren C. Denlinger, MD

Dr. Denlinger practices at University Health Services - Madison (Highland Ave) in Madison, Wisconsin.

Dr. Denlinger's NPI, 1508827411, was assigned on March 30, 2006. Dr. Denlinger graduated from University of Wisconsin School of Medicine in 1998. Dr. Denlinger holds Wisconsin license 41343.

Dr. Denlinger's primary practice is University Health Services - Madison (Highland Ave), at 600 Highland Ave, Madison, WI 53792. The practice phone is (608) 265-1978.

Dr. Denlinger's primary practice is University Health Services - Madison (Highland Ave) in Madison, Wisconsin. Dr. Denlinger is also affiliated with University Hospital. The medical group on file is UW Health. Dmand AI also links Dr. Denlinger to 1 more hospital, named with a free account. Dr. Denlinger's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Denlinger practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Denlinger's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Denlinger is licensed in Wisconsin.

CMS data shows 530 Medicare services from Dr. Denlinger across 9 procedure codes in 2024, for 248 Medicare patients. Medicare paid $8,785 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 248 Medicare patients who saw Dr. Denlinger in 2024. The largest group is 65 to 74, with 128 patients. 73% of them have high blood pressure, and 73% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Denlinger's median patient age at 66, with 55% women.

In 2024, Dr. Denlinger wrote 855 Medicare Part D claims for 106 patients. 35% of them were for generic drugs. CMS names the drug for 742 of them, across 27 drugs with 11 or more claims each, at $464,513 in total drug cost. In 2023, CMS named 817 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Denlinger for performance year 2024, reported as part of a group. Dr. Denlinger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Denlinger as offering telehealth.

Dmand AI links 106 papers to Dr. Denlinger, published from 2006 to 2025. 2019 was the busiest year, with 10. The most frequent topics are Asthma, Lung and Adrenal Cortex Hormones. Dr. Denlinger has published most often in Am J Respir Crit Care Med. Dr. Denlinger's most frequent co-authors are Sally E. Wenzel, MD, Eugene Bleecker, MD and Mario Castro, MD.

Dmand AI links Dr. Denlinger to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Asthma, Respiratory Hypersensitivity and Lung Diseases.

CMS Open Payments shows 27 general payments to Dr. Denlinger from 2 drug and device companies from 2016 to 2018. Consulting fees make up the largest share, 81% of the total. Sanofi and Genzyme US Companies paid the most, $10,813.

Dr. Denlinger graduated from University of Wisconsin School of Medicine in 1998.